Medical visionaries Dr. William Kraus and Matthew Banet bring decades of clinical and medical device insights and expertise to advise the company on clinical research, regulatory and market strategy
Valencell, the leading innovator in biometric monitoring for wearables, announced the appointment of the founding members of its medical advisory board. As Valencell continues
The newly formed medical advisory board includes two exceptional leaders in the field of medical wearables and translational research:
- Dr. William E. Kraus, board certified cardiologist, practi
cing preventive cardiology and sports cardiology at Duke University. He is well known for his expertise in the relation of physical activity and human health.
- Dr. Matthew Banet, Senior Director of R&D at Baxter and serial entrepreneur and founder of numerous med-tech start-ups including Sotera Wireless which created the first cuffless blood pressure monitor cleared by the FDA.
“The success of Valencell’s medical wearables roadmap demands expanding our clinical partnerships and proficiently navigating the regulatory environment. We are delighted to have these experts help Valencell drive its medical wearables strategy and maximize the impact our technology can have in health and medical devices, particularly in the areas of blood pressure monitoring and cardiovascular care,” said Dr. Steven LeBoeuf, president & co-founder at Valencell. “Their guidance in clinical, regulatory, and product strategy will be instrumental as Valencell’s
Dr. William E. Kraus is a physician scientist and Professor in the Division of Cardiology, Department of Medicine at Duke University School of Medicine. He is Director of Translational Research at the Duke Molecular Physiology Institute. He has been Medical Director of the Duke Cardiac Rehabilitation Program since 1994 and served as President of the American College of Sports Medicine. His undergraduate degree was in Astronomy and Astrophysics (1977) from Harvard College. He received his medical degree (1983) and training (Internal Medicine Residency and Cardiology Fellowship) all from Duke University School of Medicine. He has been principal investigator for the STRRIDE studies, a series of 3 NIH-sponsored human studies focusing on the dose-response effects of exercise training on cardiometabolic health. He served on the 2008 and 2018 Physical Activity Guidelines Advisory Committee that compiled the science supporting the US Physical activity Guidelines. He is the author of over 480 peer reviewed primary publications and reviews. Recently, Dr. Kraus has directed his research toward using biometric monitoring to understand the relation of circadian rhythms to human health, and his clinical interest to using biometric monitoring for clinical monitoring programs in the home-based cardiac rehabilitation and other cardiac prevention settings.
Matthew Banet Ph.D. is currently a Senior Director of Research and Development at Baxter. Prior to this role, Matt founded toSense Inc.—a medtech